GUFICBIO.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 06:00):

Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India...

Stats
Today's Volume	129 878
Average Volume	106 376
Market Cap	31.98B
EPS	INR0 ( 2024-02-13 )
Next earnings date	( INR0 ) 2024-05-27
Last Dividend	INR0.100 ( 2023-09-21 )
Next Dividend	INR0 ( N/A )
P/E	37.04
ATR14	INR0.476 (0.15%)

Volume Correlation

Long: -0.10 (neutral)

Short: -0.62 (weak negative)

Signal:(53.658) Neutral

Gufic Biosciences Limited Correlation

10 Most Positive Correlations
FCONSUMER.NS	0.905
SHK.NS	0.899
PRAENG.NS	0.898
SUVEN.NS	0.897
PILITA.NS	0.896
SYNCOMF.NS	0.895
BAYERCROP.NS	0.893
RAMANEWS.NS	0.892
FSC.NS	0.891
AAREYDRUGS.NS	0.89

10 Most Negative Correlations
SOMATEX.NS	-0.913
BSELINFRA.NS	-0.903
TARMAT.NS	-0.885
ABB.NS	-0.882
THERMAX.NS	-0.861
PGHL.NS	-0.858
FOSECOIND.NS	-0.846
KAYNES.NS	-0.845
MANINDS.NS	-0.845
SONATSOFTW.NS	-0.844

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Gufic Biosciences Limited Correlation - Currency/Commodity

-0.52
( weak negative )

-0.58
( weak negative )

0.00
( neutral )

-0.49
( neutral )

-0.76
( moderate negative )

0.73
( moderate )

Gufic Biosciences Limited Financials

Annual	2022
Revenue:	INR6.91B
Gross Profit:	INR3.59B (51.95 %)
EPS:	INR8.22

FY	2022
Revenue:	INR6.91B
Gross Profit:	INR3.59B (51.95 %)
EPS:	INR8.22

FY	2022
Revenue:	INR7.79B
Gross Profit:	INR3.50B (44.86 %)
EPS:	INR9.89

FY	2021
Revenue:	INR4.88B
Gross Profit:	INR2.30B (47.15 %)
EPS:	INR4.56

Financial Reports:

No articles found.

Gufic Biosciences Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.200 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0.100 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Gufic Biosciences Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.52 - low (50.05%) | Divividend Growth Potential Score: 3.50 - Decrease likely (29.98%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.220	2005-09-22
Last Dividend	INR0.100	2023-09-21
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	21	--
Total Paid Out	INR1.530	--
Avg. Dividend % Per Year	0.04%	--
Score	1.93	--
Div. Sustainability Score	4.52
Div.Growth Potential Score	3.50
Div. Directional Score	4.01	--

Next Divdend (Est)
(2024-07-01)

INR0.108 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.93

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0.0500	0.04%
2019	INR0.0500	0.05%
2020	INR0.0500	0.08%
2021	INR0.100	0.08%
2022	INR0.200	0.08%
2023	INR0.100	0.04%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SIYSIL.NS	Dividend Junior	2023-07-24	Semi-Annually	18	1.37%
MBAPL.NS	Dividend Junior	2023-09-18	Annually	8	0.44%
GUJAPOLLO.NS	Ex Dividend Junior	2023-09-22	Annually	18	0.48%
BAYERCROP.NS	Dividend Junior	2023-08-03	Annually	15	1.25%
PRESSMN.NS	Dividend Knight	2023-07-07	Annually	12	2.06%
KAMDHENU.NS	Dividend Junior	2023-08-14	Sporadic	17	0.32%
EDELWEISS.NS	Dividend Junior	2023-09-18	Annually	17	2.38%
ADSL.NS	Dividend Junior	2023-08-10	Sporadic	16	0.91%
SUBROS.NS	Dividend Junior	2023-08-22	Annually	20	0.22%
NAHARCAP.NS	No Dividend Player	2023-09-08	Annually	17	0.70%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.107	1.500	7.85	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.228	1.500	8.58	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	8.29	1.000	8.04	8.04	[3 - 30]
operatingCashFlowPerShareTTM	3.71	2.00	8.76	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.71	2.00	8.15	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.467	1.000	5.56	5.56	[0.2 - 0.8]
operatingProfitMarginTTM	0.161	1.000	8.78	8.78	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.52

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	37.40	1.000	6.32	0	[1 - 100]
returnOnEquityTTM	0.228	2.50	9.09	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.71	2.00	8.76	10.00	[0 - 30]
dividendYielPercentageTTM	0.0318	1.500	9.20	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.71	2.00	8.76	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.22	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0474	1.000	-1.315	0	[0.1 - 0.5]
Total Score				3.50

Gufic Biosciences Limited

Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai, India.